Canadian Glycomics Virtual Poster Session – June 25, 2020 Posters List Presenting at 11:20 am – 12 pm MDT # Name Title # Name Title Participation of O-GlcNAc and galectins in Adam Emily Characterization of the putative O- 1 neutrophilic differentiation of human acute 15 McTague Rodriguez acetyltransferase CcsI: role in cellulose biofilms promyelocytic leukemia HL-60 cells Developing a small molecule inhibitor of the Alexander Quantitation of acetylated and non-acetylated sialic Erum 2 16 Pseudomonas aeruginosa biofilm Garner acids found in milk samples Razvi exopolysaccharide deacetylase PelA An inactive mutant of the hexosaminidase Analysis of intramolecular hydrogen-bonding in Alexander dispersin B acts as a selective probe for the Fatma 3 17 DANA derivatives by 13C NMR spin-lattice Eddenen biofilm-associated polysaccharide poly-N- Eljabu relaxation acetylglucosamine Identification of new metabolic pathways regulating Andrew EcoCRM®, a recombinant CRM197 carrier protein Yazan 4 18 galactosaminogalactan synthesis and biofilm Lees for conjugate vaccines Abu Yousef formation Anna Synthesis and extension of AltdiNAc for the Jaesoo A shotgun mass spectrometry-based glycomics 5 19 Niedzwiecka synthesis of pseudamininc acid Jung strategy for delivering glycan ligands of CD33 Investigating O-GlcNAc and galectin gene Austin Synthesis of a novel amphiphilic cyclodextrin for Jennifer 6 20 expression in the human choriocarcinoma cell line Che liquid crystalline studies Kaminker BeWo Keegan Brian Structural and functional characterization of the Enhancing chimeric CAZyme complexes by 7 21 Turner- Lowrance Clostridioides difficile glycosyl hydrolase CcsZ introducing agarose binding modules Wood ABO-mismatched hematopoietic cell Bruce Kejia Intramolecular hydrogen bonds influence Wittig 8 transplantation and ABO tolerance: assessment of 22 Motyka Yan reaction rate by stabilizing transition state ABH subtype-specific antibodies Evaluating the role of Siglecs in regulating Bushra High-level natural anti-A antibody production and Kelli 9 23 neutrophils and monocytes using a liposome- Anjum IgM to IgG class switch in female vs male mice McCord based approach Changqing Development of novel glyco-caged prodrugs to Laura Coordinated changes of carbohydrates regulate 10 24 Wang treat enteric inflammatory diseases Streith the function of CD22 on germinal centre B cells Using metaproteomics to identify galactosidases in Diana Lena Synthesis of peptide macrocycles using 1,5- 11 the mouse gut microbiome for biomedical and 25 Czuchry Sobze dichloro-2,4-pentadione industrial applications Computational characterization of lectin binding Daniel Lyann In vivo production of sialylated therapeutic proteins 12 sites: uncovering determinants of glycan 26 Mattox Sim in E. coli recognition Gangliosides control inflammatory activation, Danny Vijay Optimization of heparan sulfate expression and 13 chemotaxis, phagocytosis and growth factor 27 Galleguillos Tejwani purification in batch shake-flask studies synthesis in mouse primary microglia Modulating intracellular ice recrystallization in Edward New approaches for studying Siglec-ganglioside Nishaka 14 28 hepatocytes using small carbohydrate-based ice Schmidt interactions William recrystallization inhibitors 1 Presenting at 12:20 pm – 1 pm MDT # Name Title # Name Title Gour Modulating phagocytosis by targeting CD33 Rui Global protein glycosylation profile is altered in 29 44 Daskhan with multivalent glycodendrimers Qin osteoarthritic equine synovial fluid Synthesis of novel Montbretin A analogs as Josh Towards the synthesis of O-glycan ligands for Ryan 30 45 specific and potent inhibitors of human Kofsky probing glycan-protein binding interactions Sweeney pancreatic amylase Developing photo-crosslinking probes to Jonathan Samantha Evaluation of bovine milk oligosaccharides 31 investigate Siglec-7-glycan interactions through 46 Babulic Bakker using tandem mass tags cell-surface glyco-engineering Teasing out the function of protein O- Lucy Samar O-Glycan sequon engineering of therapeutic 32 mannosylation in Actinobacteria: a proteomic 47 Ross-Blevis Barazesh proteins in Escherichia coli approach Calcium bridging between carbohydrates and Martin Shaiqi Molecular basis for ligand recognition by a 33 lectins: Classical molecular dynamics 48 Lepšík Guo bacterial lectin involved in biofilm formation augmented with effective electronic polarisation Chemoenzymatic synthesis of Marrie Simona 34 multiantennary N-glycans displaying 49 Janus lectins as scaffold for double specificity Boddington Notova SLeX epitopes Michel Synthesis of sialyl Lewis-x analogues as Starr Novel classes of bioactive nucleoside 35 50 Prévost selectin antagonists Dostie analogues Mostafa Optimizing linker design of human Taylor Development of high-throughput methods for 36 51 Radwan neuraminidase inhibitors Gray the analysis of dairy protein N-Glycans Nahoko Synthesis and pharmacokinetic study of Thu High-throughput mapping miRNA-glycogene 37 52 Yagami selective inhibitors of human neuraminidases Chu interactomes The development of pharmacophore, 2D and Preliminary X-Ray structure of a Fab fragment Nevin Wei 38 3D QSAR models for the discovery of novel 53 of antibody targeting tumour-associated Elsayed Li human neuraminidase inhibitors carbohydrate antigens An HPLC approach to glycoform quantification Affinity capture of endogenous O-GlcNAc Nicole Jil 39 in the development of therapeutic proteins with 54 transferase (OGT) in acute myeloid leukemia Thompson Busmann mucin type O-glycans (AML) Nageswari Chemoenzymatic methods to map glycan- Youjin Chemoenzymatic synthesis of type I and Type 40 55 Yarravarapu mediated interactions Kim II poly-LacNAc’s and their derivatives Peter Novel strategies for treatment of periodontal Zachary Probing the mechanism of glycosyltransferase 41 56 Nguyen disease and remediation of oral dysbiosis Morrison PgaCD with UDP-GlcNAc substrate analogs Princey Jonathan 42 A synthetic strategy for glycopeptide mimetics 57 Core services for glycomics research Raju Cartmell Reilly Glycan-based prebiotic adjuvants in cancer 43 Pidgeon immunotherapy 2 .